Our Clinical Focus

Oncology & CAR-T

Access China's leading oncology centers for precision immunotherapy, CAR-T cell therapy, and clinical trial access.

$15,000 – $180,000

Typical Cost Range

250,000+

Annual Cases in Network

Specialists

Why China for Oncology & CAR-T

China has more approved CAR-T products than any country globally. With 200+ active oncology clinical trials and cancer centers performing procedures at volumes that create unmatched expertise, patients gain access to treatments often years before they reach other markets.

Overview

Why China for Oncology & CAR-T

Conditions We Treat

Gastric and gastrointestinal cancers
B-cell lymphoma and leukemia
Multiple myeloma
Acute promyelocytic leukemia (APL)
Head and neck cancers
Proton therapy-indicated tumors

Specialists in Oncology & CAR-T

Zhao Weili

赵维莅

Chief Physician, Professor, Doctoral Supervisor; Vice President of Ruijin Hospital

The Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

23+ career cases (haodf.com)

Huang He

黄河

Professor and Chief Physician

1,400 Outpatient hematology consultations/year (zy91.com)

Li Junmin

李军民

Chief Physician, Doctoral Supervisor, Deputy Director of Hematology, and Deputy Director of the Shanghai Institute of Hematology

The Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

1,780+ career cases (haodf.com)

Lugui Qiu

邱录贵

Chief Physician; Clinical Chief Expert; Tenured Associate Professor; Doctoral Supervisor

Built one of China’s leading lymphoma and myeloma clinical-translational programs at the Institute of Hematology CAMS, with official profiles crediting him for establishing advanced diagnostic and treatment systems that improved outcomes.

Ji Jiafu

季加孚

Professor of Surgery; Chief Expert, Gastrointestinal Cancer Center; Director, Department of Surgery

Peking University Cancer Hospital

400 Gastric and gastrointestinal cancer surgery performed personally/year (bjcancer.org.cn)

Guo Xiaomao

郭小毛

Professor, Chief Physician, Doctoral Supervisor, Party Secretary and President of Fudan University Shanghai Cancer Center, and President of Shanghai Proton and Heavy Ion Center

Fudan University Shanghai Cancer Center

Official SPHIC and FUSCC profiles position Guo Xiaomao as the current physician-leader of Shanghai's proton and heavy-ion program, serving as both the hospital president and Clinical Technology Committee Director.